Related references
Note: Only part of the references are listed.Brain-Penetrant LSD1 Inhibitors Can Block Memory Consolidation
Ramesh Neelamegam et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors
Hanae Benelkebir et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor
Daisuke Ogasawara et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, Part 1
Savina Malancona et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a] pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, Part 2
Olaf Kinzel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) Mice
Volker M. Arlt et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Crystal Structure of tert-Butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in Complex with HIV-1 Reverse Transcriptase (RT) Redefines the Elastic Limits of the Non-nucleoside Inhibitor-Binding Pocket
Kalyan Das et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A Practical Use of Ligand Efficiency Indices Out of the Fragment-Based Approach: Ligand Efficiency-Guided Lead Identification of Soluble Epoxide Hydrolase Inhibitors
Daisuke Tanaka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Lysine Demethylases Inhibitors
Takayoshi Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Serotonin receptors and heart valve disease-It was meant 2B
Joshua D. Hutcheson et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Discovery of novel selective Sigma-1 ligands as cognitive enhancers
Anne Valade et al.
MEDCHEMCOMM (2011)
Rational Drug Design Leading to the Identification of a Potent 5-HT2C Agonist Lacking 5-HT2B Activity
Gang Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Structurally Designed trans-2-Phenylcyclopropylamine Derivatives Potently Inhibit Histone Demethylase LSDI/KDM1
Shinya Mimasu et al.
BIOCHEMISTRY (2010)
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
Soyoung Lim et al.
CARCINOGENESIS (2010)
AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function
Ze Yang et al.
CELL RESEARCH (2010)
HTS and Rational Drug Design to Generate a Class of 5-HT2C-Selective Ligands for Possible Use in Schizophrenia
Alan P. Kozikowski et al.
CHEMMEDCHEM (2010)
Potentiation of Ligand Binding through Cooperative Effects in Monoamine Oxidase B
Daniele Bonivento et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2
Claudia Binda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
TCP-FA4: A derivative of tranylcypromine showing improved blood-brain permeability
Kelly E. Desino et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
Johannes H. Schulte et al.
CANCER RESEARCH (2009)
(1R, 3S)-(-)-Trans-PAT: A novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity
Raymond G. Booth et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Smoothened antagonists: a promising new class of antitumor agents
Paola Gallinari et al.
EXPERT OPINION ON DRUG DISCOVERY (2009)
A Novel Mammalian Flavin-dependent Histone Demethylase
Aristotele Karytinos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action
Sung Jin Cho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Identification of Cell-Active Lysine Specific Demethylase 1-Selective Inhibitors
Rie Ueda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Engagement of the Lysine-Specific Demethylase/HDAC1/CoREST/REST Complex by Herpes Simplex Virus 1
Haidong Gu et al.
JOURNAL OF VIROLOGY (2009)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 Å
Shinya Mimasu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Fluorinated phenylcyclopropylamines.: Part 5:: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases A and B by 2-aryl-2-fluoro-cyclopropylamines
Svenja Hruschka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B
David M. Gooden et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Carba-nucleosides as potent antagonists of the adenosine 5′-diphosphate (ADP) purinergic receptor (P2Y12) on human platelets
Hong Ye et al.
CHEMMEDCHEM (2008)
Fluorinated phenylcyclopropylamines Part 6. Effects of electron withdrawing or donating aryl substituents on the inhibition of tyramine oxidase from Arthrobacter sp by diastereomeric 2-aryl-2-fluoro-cyclopropylamines
Svenja Hruschka et al.
JOURNAL OF FLUORINE CHEMISTRY (2008)
Structure of human monoamine oxidase A at 2.2-Å resolution:: The control of opening the entry for substrates/inhibitors
Se-Young Son et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hedgehog Signaling Pathway: Development of Antagonists for Cancer Therapy
Jingwu Xie
CURRENT ONCOLOGY REPORTS (2008)
An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma(1) receptor ligand
Teruo Hayashi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
From ATP to AZD6140:: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis
Brian Springthorpe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors
Madhavi Pannala et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Fluorine in pharmaceuticals:: Looking beyond intuition
Klaus Mueller et al.
SCIENCE (2007)
p53 is regulated by the lysine demethylase LSD1
Jing Huang et al.
NATURE (2007)
Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine
Maojun Yang et al.
BIOCHEMISTRY (2007)
New insights into the structures and functions of human monoamine oxidases A and B
D. E. Edmondson et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
trans-2-phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1
Dawn M. Z. Schmidt et al.
BIOCHEMISTRY (2007)
Structural basis of histone demethylation by LSD1 revealed by suicide inactivation
Maojun Yang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Tranylcypromine - New perspectives on an old'' drug
Helge Frieling et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2006)
Crystal structure and mechanism of human lysine-specific demethylase-1
Pete Stavropoulos et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
The role of ADP receptors in platelet function
S Murugappan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis:: a double-blind comparison to clopidogrel with aspirin
S Husted et al.
EUROPEAN HEART JOURNAL (2006)
The platelet ATP and ADP receptors
C Oury et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications
Min Gyu Lee et al.
CHEMISTRY & BIOLOGY (2006)
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids. I. Synthesis and biological evaluation of lipophilic conjugates of tranylcypromine
R Pignatello et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Pharmacophore identification for sigma-1 (σ1) receptor binding:: Application of the deconstruction reconstruction elaboration approach
RA Glennon
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B
L De Colibus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Fluorinated phenylcyclopropylamines.: Part 4:: Effects of aryl substituents and stereochemistry on the inhibition of monoamine oxidases by 1-aryl-2-fluoro-cyclopropylamines
S Ye et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase
S Yoshida et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
Epidermal growth factor receptor inhibition strategies in oncology
PM Harari
ENDOCRINE-RELATED CANCER (2004)
Fluorinated phenylcyclopropylamines.: 2.: Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxidase
TC Rosen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Antitussive activity of sigma-1 receptor agonists in the guinea-pig
C Brown et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B
S Yoshida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures
C Binda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Higher-end serotonin receptors:: 5-HT5, 5-HT6, and 5-HT7
RA Glennon
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine
EM Shepard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2003)
The epidermal growth factor receptor-tyrosine kinase: A promising therapeutic target in solid tumors
CA Ritter et al.
SEMINARS IN ONCOLOGY (2003)
Medulloblastoma growth inhibition by Hedgehog pathway blockade
DM Berman et al.
SCIENCE (2002)
Probing the catalytic mechanism of Escherichia coli amine oxidase using mutational variants and a reversible inhibitor as a substrate analogue
CG Saysell et al.
BIOCHEMICAL JOURNAL (2002)
Human kidney diamine oxidase: heterologous expression, purification, and characterization
BO Elmore et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2002)
Hedgehog signaling in animal development: paradigms and principles
PW Ingham et al.
GENES & DEVELOPMENT (2001)
An elusive receptor is finally caught:: P2Y12, an important drug target in platelets
EA Barnard et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Spectrometric evidence for the flavin-1-phenylcyclopropylamine inactivator adduct with monoamine oxidase N
DJ Mitchell et al.
BIOCHEMISTRY (2001)
Mechanisms of action of antimicrobials: Focus on fluoroquinolones
DC Hooper
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
